P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia

Area of Science:

• Immunology
• Cell Biology
• Physiology

Background:

• Polymorphonuclear neutrophil (PMN) accumulation in damaged tissues is a key feature of acute inflammation.
• P-selectin and platelet activating factor (PAF) are implicated in the initial adhesion of PMNs to endothelial cells.
• Understanding the in vivo mechanisms of PMN adhesion is critical for inflammatory disease research.

Purpose of the Study:

• To investigate the in vivo roles of P-selectin and PAF in early PMN adhesion to endothelial cells.
• To examine the effects of lipopolysaccharide (LPS) on PMN behavior and endothelial cell markers in vivo.
• To determine the efficacy of P-selectin antibodies and PAF antagonists in blocking PMN adhesion.

Main Methods:

• Intravenous LPS administration to anesthetized rats to induce inflammatory responses.
• Monitoring for rapid onset neutropenia (low PMN count) post-LPS injection.
• Assessing P-selectin expression on microvascular endothelial cells in kidney, liver, and lung.
• In vitro studies using cultured endothelial cells stimulated with LPS.
• Treatment with anti-P-selectin antibody or PAF antagonist to evaluate their blocking effects.

Main Results:

• LPS administration rapidly induced neutropenia (< 5 min) in rats.
• LPS stimulated P-selectin expression on microvascular endothelial cells in multiple organs.
• P-selectin expression was also induced in vitro by LPS in cultured endothelial cells.
• Anti-P-selectin antibody or PAF antagonist treatment significantly blocked LPS-induced neutropenia.
• Antibody treatment inhibited PMN accumulation in tissues.

Conclusions:

• P-selectin and PAF play significant roles in the early stages of PMN adhesion to endothelial cells in vivo.
• LPS triggers a rapid inflammatory cascade involving P-selectin and PAF.
• Targeting P-selectin and PAF may offer therapeutic strategies for inflammatory conditions.